** Shares of Immuron Ltd IMC.AX rise as much as 30.6% to
A$0.094, their highest level since Aug. 31
** Biopharmaceutical co receives U.S. Food and Drug
Administration approval for Travelan Investigational New Drug
application (IND)
** Says IND was submitted to evaluate the efficacy of single
dose of Travelan to prevent infectious diarrhea caused by
Enterotoxigenic E. coli bacteria
** Co's set for best day since Dec. 1, if gains hold
** About 2.27 mln shares trade hands compared to 30-day
average trading volume of 99,700 shares
** Shares of co are down 28% YTD as of last close
(Reporting by John Biju in Bengaluru)
((John.Biju@thomsonreuters.com;))